As the annual Dry AMD Therapeutics Summit runs in person for the first time, we are once again bringing together leading innovative biopharma companies looking to reach patients which their life changing therapeutics.
100+ Industry Stake Holders
30+ Expert Speakers
5+ Hours of Networking Opportunities
This conference offers the unmissable opportunity to connect with senior decision makers in top companies such as IVERIC, Apellis, Janssen, Novartis, Genentech, AbbVie & many more, and forge valuable relationships through the two days of content.
What is the industry looking for?
Novel Biomarker Determining Technologies – Retinal/Ocular Imaging
As the field continues to look for more viable endpoints for their clinical trials, structural endpoints are becomingly an increasingly desirable; take this opportunity to showcase the quality of your technology and depth of your expertise in this area.
Efficacious Preclinical Models, Safety and Efficacy Testing - Preclinical CROs
Preclinical studies continue to prove difficult for this field as recapitulation of the human eye and dry AMD progression isn't currently possible. Use this opportunity to show your off your problem-solving skills and help the industry overcome this glaring challenge.
Clinical Trial Execution & Expertise – Clinical CROs
Patient retention and surgical complications with delivery are huge challenges for this industry, as dry AMD requires frequent, invasive procedures. Showcase your effective execution of clinical trials to accelerate these drugs through the most crucial stages of drug trials.
If you have the above expertise or think you can benefit the industry through another avenue, get in touch with us and We will work with you to build a bespoke partnership package to showcase your expertise to this niche audience of industry decision makers in the ophthalmic space.